Pro-Dex Corp (PDEX) - Multiplikator forward rega marang pendapatan

pro-dex.com (PDEX) - logo korporat

The stability of Pro-Dex, Inc. (PDEX) relies on long-term agreements with market leaders, with 3.00 serving as the base parameter value. The expected price-to-sales ratio visualizes the balance between demand and revenue forecasts. This trend is supported by the development of smart actuators through partnerships with OEM brands and deep expertise in maxillofacial surgery, enabling the rapid modernization of high-precision instruments to meet clinic requirements.

PDEX pro-dex.com: Multiplikator forward rega marang pendapatan ing interval 04.07.2022 - 13.11.2026

Pro-Dex Inc. - rincian analitis lan metrik utama (PDEX)

- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
Analisis umum perusahaan:PDEX (Pro-Dex)
Produk asli pro-dex.com

The forward P/S reflects the market value of Pro-Dex, Inc. (PDEX) relative to expected future sales, allowing investors to assess the premium paid for every dollar of revenue. By analyzing P/S expectations for Pro-Dex, Inc. (PDEX) on GURU.Markets, one can correlate the multiple's dynamics with the volume of orthopedic surgeries and the stability of OEM contracts, which determine the real scaling potential of the business within the medical sector.

Analisis perusahaan pesaing

Rasio rega marang prakiraan pendapatan Intuitive ISRG|Rega forward marang dodolan DHR|BDX: Multiplikator forward rega marang pendapatan|STE - Multiplikator Forward P/S|West Pharmaceutical Services (WST) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan baxter.com|MASI (Masimo) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Stevanato Group SpA STVN|Rasio rega marang prakiraan pendapatan Teleflex Inc (TFX)|Merit Medical Corp - Kapitalisasi marang prakiraan pendapatan|Envista Holdings - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ICUI (icumed.com)|XRAY - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake LeMaitre Vascular Inc LMAT|AtriCure Corp (ATRC) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan STAA (STAAR Surgical Co)|Rasio rega marang prakiraan pendapatan ChromaDex Corporation|ZIMV: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan AngioDynamics (ANGO)|CERS - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Alpha Teknova Inc - Multiplikator forward rega marang pendapatan|Prakiraan rega marang pendapatan Monogram Orthopedics Inc.|Sharps Tech - Multiplikator Forward P/S|INFU (InfuSystem Holdings) - Kapitalisasi marang prakiraan pendapatan|UTMD: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep KORU Medical (KRMD)|Multiplikator forward rega marang pendapatan NYXH|Kapitalisasi marang prakiraan pendapatan MBOT (Microbot Medical, Inc)|Multiplikator forward rega marang pendapatan ZTEK (Zentek Ltd.)|ELUT (elutia.com) - Rega forward marang dodolan|Multiplikator Forward P/S MLSS (Milestone Scientific Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake NEXGEL Inc. (NXGL)|RVP - Rasio rega marang prakiraan pendapatan|HBIO (harvardbioscience.com) - Kapitalisasi marang prakiraan pendapatan|FEMY: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Meihua Medical Technologies Co., Ltd.|Multiplikator forward rega marang pendapatan POAI|Callan JMB Corp (CJMB) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Atrion Corp (ATRI)|NURO: Rega mangsa ngarep marang pendapatan